Analyst: This Drug Name is a "Top Pick"

Gilead stock ran into resistance at the 200-day moving average last week

Managing Editor
Jul 29, 2019 at 9:13 AM
facebook twitter linkedin


Shares of drugmaker Gilead Sciences, Inc. (NASDAQ:GILD) are up 1.5% in pre-market trading, after the stock received an upgrade to "top pick" from "outperform" out of RBC. The brokerage firm cited new leadership as one reason for its bullish view on GILD stock. Overall, analysts have been extremely optimistic toward the security, with 14 of 19 covering firms sporting a "strong buy" rating, while just five carry a tepid "hold," and the stock's average 12-month price target stands at $80.19, compared to Friday's close of $66.92.

GILD has had a lackluster year on the charts, but despite last week running into resistance at the 200-day moving average, the stock remains 6% higher-year-to-date. We'll see if earnings, due out after the close tomorrow July 30, can spark some more upside for the shares.

However, the security has averaged a modest post-earnings move of just 2.7% during the past two years. Ahead of the event, call buying has remained popular at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), with the 10-day call/put volume ratio at these exchanges standing at 2.45. In the front-month August series, peak call open interest sits at the 70 strike.

 

 

 

These investors are using the market's volatility to their advantage and scoring triple-digit gains on many of their trades.

Even in today's sideways bear market, this trading strategy has continued to provide consistency and profitability to a small group of investors. By using this approach, these traders are removing directional risk and still hitting triple-digit returns. If you want access to this strategy, and lower risk with higher returns sounds good to you, then don't wait another minute.

Join us now to receive our next trades the moment they come out!

 

Common mistakes options traders make
 


 


 
Special Offers from Schaeffer's Trading Partners